Abstract
Evaluates long-term clinical outcomes of percutaneous coronary intervention (PCI) with bioresorbable vascular scaffold (BVS) versus minimally invasive direct coronary artery bypass (MIDCAB) surgery for the treatment of left anterior descending (LAD) lesions. In this single-center study were included 130 patients with stable angina and significant (≥ 70 %) LAD disease. Patients were randomly assigned in a 1:1 ratio to PCI with everolimus-eluting BVS (n=65) or MIDCAB (n=65). Theprimary end-point was major adverse cerebro-cardiovascular events (MACCE) and secondary was scaffold (graft) thrombosis at1year. The groups of patients were comparable for all baseline demographic, clinical and angiographic parameters. MACCE at12month occurred in 9.2 % of patients in the BVS group and in 4.6 % of patients in the MIDCAB group (p=0.3). There was no significant difference between the groups in rates of all cause death (1.5 % vs 1.5 %, p=1.0), myocardial infarction (3.1 % vs. 6.1 %, p=0.4), any revascularization (1.5 % vs. 6.1 %, p=0.1) and scaffold (graft) thrombosis (1.5 % vs. 1.5 %, p=1.00). At 12-month follow up, there was no significant difference in the rate of MACCE between PCI by BVS and MIDCAB in patients with isolated LAD lesions.
Highlights
Patients were randomly assigned in a 1:1 ratio to percutaneous coronary intervention (PCI)
major adverse cerebro-cardiovascular events (MACCE) at 12 month occurred in 9.2 % of patients
There was no significant difference between the groups in rates
Summary
Малоинвазивная реваскуляризация миокарда (MIDCAB) и чрескожное коронарное вмешательство (ЧКВ) являются альтернативными методами реваскуляризации у пациентов с изолированным поражением передней нисходящей артерии (ПНА). По результатам мета-анализа, MIDCAB снижает риск повторной реваскуляризации и развития ССО на протяжении 12 мес наблюдения по сравнению с ЧКВ.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.